InTouch Health Receives FDA Clearance for the RP-VITA™ Remote Presence Robot

  InTouch Health Receives FDA Clearance for the RP-VITA™ Remote Presence Robot

RP-VITA Auto Drive and iPad® App extend remote care with unprecedented ease of
                                     use

2013 International CES

Business Wire

SANTA BARBARA, Calif. -- January 8, 2013

InTouch Health, the leader in acute care telemedicine, today announced it has
received a U.S. Food and Drug Administration (FDA) 510(k) clearance for the
RP-VITA Remote Presence Robot. The RP-VITA is the first telemedicine robot
designed for remote doctor-to-patient consults that combines state-of-the-art
telecommunications and autonomous navigation technology. The RP-VITA is FDA
cleared for telemedicine consults inclusive of active patient monitoring in
high-acuity environments where immediate clinical action may be required. The
FDA clearance specifically allows RP-VITA to be used for active patient
monitoring in pre-operative, peri-operative and post-surgical settings,
including cardiovascular, neurological, prenatal, psychological and critical
care assessments and examinations.

The RP-VITA is a multi-faceted medical device platform that features Auto
Drive and an iPad user interface that gives it unprecedented ease of use and
versatility for delivering high-acuity telemedicine. RP-VITA merges seamlessly
with existing hospital processes to provide state-of-the-art audiovisual
capabilities with a high-quality interactive experience. Furthermore, the
RP-VITA platform was designed with a full range of clinical capabilities for
delivering services like TeleStroke and TeleICU today that can be expanded to
integrate patient data and enable other important clinical functions in the
future. Enhancing efficiency through ease of use and care coordination,
RP-VITA sets a new standard of performance for delivering acute care remotely.

“RP-VITA brings to market a true next-generation remote presence solution that
will enable many new clinical applications and uses,” said Yulun Wang, Ph.D.,
Chairman and CEO of InTouch Health. “We are proud to have achieved this
regulatory objective with the autonomous navigation capability for RP-VITA and
are absolutely committed to the highest standards for safety and efficacy. We
are pleased to provide customers the assurance of knowing that our
telemedicine solutions have withstood rigorous clinical testing and are fully
compliant with FDA regulations.”

“RP-VITA raises the bar for acute care telemedicine solutions for patient care
delivery. The Robot allows me to effortlessly follow the entire clinical
workflow process, and puts me at the point of care precisely when and where I
need to be,” said Paul Vespa, M.D., Director of Neurocritical Care, UCLA
Health System, and Associate Professor of Neurosurgery and Neurology at the
UCLA School of Medicine. “As a thought-leader in today’s challenging health
care environment, we at UCLA are very pleased to have participated in the
clinical development and validation of this revolutionary health care delivery
platform.”

The RP-VITA Robot will be featured during the Digital Health Summit at the
Consumer Electronics Show (CES) on January 9, 2013, 9:00 am at the Las Vegas
Convention Center. The presentation, Digital Health Confidential, will be
moderated by Dr. Sanjay Gupta, Chief Medical Correspondent for CNN News, and
will include as panelists Dr. Yulun Wang, Chairman and CEO, InTouch Health,
and Colin Angle, Chairman and CEO, iRobot.

About InTouch Health

InTouch Health is the leader in providing telemedicine solutions for
high-acuity applications where doctors are required to take immediate clinical
action. Its InTouch® Telemedicine System is the industry’s only fully
integrated end-to-end solution encompassing clinical data management, medical
imaging, 24/7 technical support, clinical consulting services and the
SureConnect® cloud-based infrastructure. By removing time and distance
barriers, the InTouch Telemedicine System effectively enables physicians to
perform real-time consults with hospital patients through a host of
purpose-built telemedicine devices. Deployed on six continents, over 10% of
all U.S. hospitals – including 13 of the nation’s top neuroscience centers of
excellence – use the InTouch Telemedicine System.

Contact:

InTouch Health
Roselie Wright, 805-562-8686 x177
rwright@intouchhealth.com
 
Press spacebar to pause and continue. Press esc to stop.